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Despite the improvement of myocardial 
preservation during cardiac surgery, myocardial 
damage is inevitable. Cardioplegia is an essential 
strategy, which provides motionless cardiac 
surgery and preserves the myocardium. Several 
cardioplegia additives and techniques have been 
proposed; however, the optimal cardioplegic 
solution has not been reached yet [1].  
In Press
Abstract 
Background: The optimal cardioplegic solution is still debated. The objective of this 
study was to compare the effect of cold crystalloid versus warm blood cardioplegia 
on the myocardial injury during coronary artery bypass grafting.  
Methods: The study included 34 consecutive patients who underwent elective 
primary on-pump isolated coronary artery bypass grafting from 2016 to 2019. We 
randomly assigned the patients into two groups. Group (ICCC) (n= 17) received 
intermittent antegrade cold crystalloid cardioplegia and Group (IWBC) (n= 17) 
received intermittent antegrade warm blood cardioplegia.  
Results: There was no difference in the preoperative and operative variables 
between groups. The time taken by the heart to regain normal sinus rhythm was 
significantly longer in the cold crystalloid group (7.06 ± 1.8 vs. 2.17 ± 0.8 minutes, 
p<0.001) with a higher rate of reperfusion ventricular arrhythmia (35% versus 6%; 
p=0.03) compared to the warm blood cardioplegia group. Both coronary sinus acid 
production and lactate level were significantly higher in the warm blood group than 
in the cold crystalloid group (p< 0.001 and 0.043, respectively). The ischemic ECG 
changes and the severity of new segmental wall motion abnormalities were non-
significantly different between both groups (p= 0.68 and 0.67, respectively). 
Postoperative CK-MB and cTnI levels in all-time points were not significantly 
different between groups (p= 0.46 and 0.37, respectively). ICU (2.29 ± 0.77 vs. 2.41 
± 0.87 days, p= 0.68) and hospital stay (9.28 ± 0.76 vs. 9.42 ± 0.88 days, p= 0.62) were 
non-significantly different between both groups.  
Conclusion: Intermittent antegrade cold crystalloid cardioplegia was associated with 
attenuated myocardial metabolism. However, it was associated with a longer time 
to regain normal sinus rhythm and more reperfusion ventricular arrhythmias. We 
did not find differences in the clinical and echocardiographic outcomes and cardiac 











Cardioplegia can be achieved either by 
crystalloid (cold) or blood-based (warm or cold); it 
can be given continuously or intermittently via 
antegrade or retrograde routes. Cold crystalloid 
cardioplegic solutions include the extracellular 
group as (St Thomas' solution and its 
modifications) where it contains a high 
concentration of sodium, calcium, and magnesium 
and the intracellular group as Custodiol (HTK) 
[histidine - tryptophan -ketoglutarate] where it 
consists of a low concentration of sodium and 
calcium. Both types have a high concentration of 
potassium [2, 3]. Custodiol cardioplegia is 
believed to be convenient, simple to deliver, and 
less time-consuming. Custodial cardioplegia 
induces cardiac arrest in diastole via 
hyperpolarization that mimics the natural heart 
resting state to minimizes metabolic demand and 
decreasing ATP depletion, thus improving the 
heart conditions at surgery conclusion. On the 
contrary, cold cardioplegic solutions induce 
cardiac arrest by membrane depolarization and 
have several advantages, including economical 
cost, while achieving satisfactory clinical results 
and efficacy in different patients’ groups.  
Warm heart surgery is achieved through 
continuous perfusion of blood cardioplegia. 
During coronary artery grafting (CABG), perfusion 
is usually interrupted for better visualization 
during distal coronary anastomosis [4]. Blood 
cardioplegia provides a more physiological 
environment for the myocardium; however, it can 
impair visualization during the construction of 
coronary anastomoses [1]. 
Currently, the optimal method for cardioplegia 
delivery to minimize myocardial injury is 
unknown. Moreover, there is an ongoing debate 
about the blood temperature if blood cardioplegia 
is used; additionally, the optimal delivery media, 
either blood or crystalloid, is still debated [5]. 
Consequently, there no standardized practice 
among surgeons [6, 7]. Meta-analyses were 
published comparing different cardioplegic 
solutions [8]; however, the included studies 
contained heterogeneous populations.  
Myocardial injury is more evident in a 
particular subset of patients, such as those with 
Table 1: Preoperative data in both study groups. Continuous data are presented as mean± SD and categorical variables 
as number and percent. 
Variables ICCC group (n=17) IWBC group (n=17) p value 
Age (Years) 56.0 ± 7.7 54.7 ± 7.4 0.638 
Male/Female 11/6 13/4 0.452 
Height (cm) 1.763 ± .044 1.774 ± .0385 0.441 
Weight (kg) 89.1 ± 7.8 88.1 ± 8.1 0.733 
BMI (kg/m2) 30.7 ± 3.2 30.0 ± 2.9 0.509 
ASA (II/III) 9/8 6/11 0.300 
Diabetes  9 (52.9%) 11 (64.7%) 0.486 
Hypertension  9 (52.9%) 7 (41.2%) 0.492 
Diabetic hypertensive 6 (35.3%) 4 (23.5%) 0.452 
Smoking 8 (47.1%) 11 (64.7%) 0.300 
Number of diseased vessels 
     One  
     Two  
     Three 










Preoperative wall motion abnormality 
     Mild hypokinesia 






Preoperative LVEF (%) 52.47 ± 5.23 51.29 ± 5.42 0.525 
ASA: American Society of Anesthesiology; ICCC: intermittent cold crystalloid cardioplegia; IWBC: 
intermittent warm blood cardioplegia; LVEF: left ventricular ejection fraction.  






impaired ventricular function. Myocardial injury 
may manifest clinically as low cardiac output 
syndrome, arrhythmias, or segmental heart wall 
motion abnormalities [9]. Several studies have 
compared warm and cold cardioplegia with no 
conclusive outcomes. The objective of this study 
was to compare the effect of cold crystalloid 
versus warm blood cardioplegia on the myocardial 
injury during coronary artery bypass grafting. 
Patients and Methods: 
Patients and study design: 
This research is a randomized controlled 
clinical trial that was conducted from July 2016 to 
February 2019. The trial included 34 patients who 
underwent elective primary on-pump isolated 
coronary artery bypass grafting (CABG). We 
included adult patients (age ranged from 21 to 60 
years), the body mass index (BMI) should be ˃ 20 
kg/m2 and < 34 kg/m2, and the American Society 
of Anesthesiologists (ASA) physical status Grade II 
and III. We excluded patients with left ventricular 
ejection fraction (EF) < 40%, pre-existing atrial 
fibrillation (AF), recent myocardial infarction (MI), 
unstable angina, carotid stenosis (˃ 80%), and 
renal impairment (creatine >200 mmol/L). 
Additionally, we excluded patients who had redo 
CABG or CABG with other concomitant 
procedures.  
Randomization and grouping 
We generated random blocks using computer 
software, and we randomly assigned the patients 
into two groups. Group (ICCC) (n= 17) received 
intermittent antegrade cold crystalloid 
cardioplegia and Group (IWBC) (n= 17) received 
intermittent antegrade warm blood cardioplegia. 
Operative steps 
Anesthesia protocol and monitoring were the 
same in both groups. We used a transesophageal 
echocardiography probe in all patients. All 
patients had CABG through a median sternotomy 
incision and aortocaval cannulation. 
Cardiopulmonary bypass priming was similar in 
both groups. Coronary artery bypass surgery was 
performed using the left internal mammary artery 
graft (LIMA) to the left anterior descending artery 
(LAD) in all patients, and saphenous vein grafts to 
the right coronary artery and/or to the left 
circumflex artery branches. Distal anastomoses 
were constructed during the total aortic cross-
clamp on the arrested heart. Proximal 
anastomoses were performed by partial side-bite 
clamping of the ascending aorta with the heart 
beating. Additional analgesia was administered 
according to the individual requirements of each 
patient. Inotropic support was routinely used.  
Cardioplegia protocol 
The route of delivery was exclusively 
antegrade in both groups. Antegrade cardioplegia 
was injected directly into the aortic root at 60 to 
100 mmHg pressure immediately after aortic 
cross-clamping and until cardiac arrest had been 
achieved. The heart usually arrested within 30 to 
60 seconds; delay indicated problems with the 
delivery of the solution or unrecognized aortic 
regurgitation.  
Table 2: Operative data in both study groups. Continuous data are presented as mean± SD and categorical variables 
as number and percent 
Variables ICCC group (n=17) IWBC group (n=17) p value 
CPB time (min) 79.0 ± 8.7 82.9 ± 11.0 0.255 
Aortic cross-clamp time (min) 38.8 ± 10.8 45.5 ± 12.1 0.102 
Volume of cardioplegic solution (ml) 1294.1 ± 356.1 1658.8 ± 490.8 0.019 
Time to regain NSR (min) 7.06 ± 1.8 2.17 ± 0.8 <0.001 
Reperfusion arrhythmia 
     Atrial 2 (11.8%) 1 (5.9%) 0.545 
Ventricular 6 (35.3%) 1 (5.9%) 0.03 
Number of DC shocks 5 (29.4%) 2 (11.8%) 0.22 
ICCC: intermittent cold crystalloid cardioplegia; IWBC: intermittent warm blood cardioplegia; CPB: 










Coronary sinus pH P 
value 
Coronary sinus lactate (mmol/l) p 
value Pre-XCL XCL off Rep Pre-XCL XCL off Rep 
ICCC 7.40 ± 0.03 7.52 ± 0.02 7.46 ± 0.03 
<0.001 
0.79 ± 0.10 0.79 ± 0.10 1.56 ± 0.41 
0.043 
IWBC 7.39 ± 0.02 7.34 ± 0.03 7.37 ± 0.02 0.78 ± 0.09 0.78 ± 0.09 2.13 ± 1.04 
ICCC: intermittent cold crystalloid cardioplegia; IWBC: intermittent warm blood cardioplegia; Pre-XCL: 
before aortic clamping; XCL off: 1 min after removal of the clamp; Rep: 15 min after reperfusion.  
Intermittent antegrade cold crystalloid 
cardioplegia:  
We used Thomas cardioplegia solution in the 
following concentration in mEq/L (K = 16, Ca = 1.2, 
Na = 110, Cl = 160, Hco3 = 10). We administered 
intermittent antegrade cold (4 °C) crystalloid 
cardioplegia in a dose of 10 mL/kg, followed by a 
half dose every 25–30 minutes at a pressure of 60-
100 mmHg over 3-4 minutes. Myocardial 
protection was completed by additional topical 
cardiac cooling using ice slush and repeated when 
the slush had melted. Systemic cooling was held to 
30°C. The mean number of cardioplegia doses was 
1.59±0.71. 
Intermittent antegrade warm blood cardioplegia: 
We infused normothermic blood cardioplegia 
containing K+ in a concentration of 2 mEq/ml into 
the aortic root. The temperature of the perfusate 
was34–35 °C, and the first dose was 600 mL, 
followed by doses of 400 mL each over 2 minutes 
every16–20 minutes. The mean number of 
cardioplegia doses was 1.94±0.56. 
Ethical issues: 
Written informed patient consent was 
obtained from all patients before enrollment. The 
study was conducted in accordance with the 
guidelines of the Helsinki Declaration on human 
experimentation. Patients retained the right to 
refuse enrollment or withdraw from the study. 
The study presented minimal harm since both 
types of cardioplegia were in clinical use. 
Data collection and endpoints: 
Participant characteristics (demographics and 
clinical features) were recorded. Procedure 
characteristics, including cardiopulmonary bypass 
and aortic cross-clamp times, reperfusion-induced 
arrhythmia (supraventricular or ventricular), and 
the number of direct-current shocks required to 
convert to sinus rhythm were identified and 
reported. Data related to cardioplegia were the 
number of doses, and total volume administered.  
Myocardial metabolism was assessed before 
aortic clamping, 1 minute after removal of the 
clamp, and 15 min after reperfusion. Blood 
samples were collected from coronary sinus by the 
surgeon. Blood samples were analyzed for pH and 
lactate. 
Table 4: Clinical indicators of intraoperative myocardial injury. Continuous data are presented as mean± SD and 
categorical variables as number and percent. 
Variables ICCC group (n=17) IWBC group(n=17) p value 
ECG changes 
    ST-elevation 4 (23.5%) 3 (17.6%) 
0.678 ST-depression 2 (11.8%) 1 (5.9%) 
New Qs 0 1 (5.9%) 
LVEF (%) 
    15 minutes after CPB 55.06 ± 9.18 55.53 ± 10.06 
0.3 
 Sternal closure 55.53 ± 9.44 57.41 ± 11.18 
ICCC: intermittent cold crystalloid cardioplegia, IWBC: intermittent warm blood cardioplegia, LVEF: left 
ventricular ejection fraction, CPB: cardiopulmonary bypass.  





Both creatine kinase-MB (CK-MB) and cardiac 
troponin I (cTnI) levels were evaluated in 
peripheral blood at 6, 12, and 24 hours 
postoperatively. 
Intraoperative myocardial ischemia was 
detected by the occurrence of new segmental wall 
motion abnormalities (SWMAs) using two-
dimensional transesophageal echocardiography 
(TEE) and/or ST-segment changes on ECG.  
Hemodynamic data were obtained, including 
absolute values of mean arterial pressure (MAP) 
and heart rate (HR). Left ventricular function was 
assessed using transesophageal 
echocardiography. For all patients, baseline 
measurements were recorded after skin incision. 
Recordings were also made 15 minutes after 
cessation of cardiopulmonary bypass and after 
sternal closure.  
Low output syndrome (LOS) was defined as the 
need for high dose inotropic support (epinephrine 
> 0.05 μg kg/min) or intra-aortic balloon pump 
(IABP) counterpulsation for ≥60 minutes in 
association with systolic blood pressure <90 mm 
Hg.  
Stroke, atrial fibrillation (AF), the need for new 
renal dialysis, hospital, and intensive care unit 
stays were recorded. 
Statistical analysis: 
The statistical analysis was performed using 
IBM SPSS Statistics® 22 for Windows 10 operating 
system (IBM Corp, Chicago, IL, USA). Descriptive 
data were expressed as mean and SD for 
continuous variables, and number and 
percentages (%) for dichotomous and categorical 
variables. Continuous data were compared 
between both groups using the t-test or Mann-
Whitney test. Categorical data were analyzed 
using the Chi-square or Fisher exact test when 
appropriate.  
Repeated measures one-way analysis of 
variance (ANOVA) was used to analyze the 
continuous, repeatedly measured variables. The 




Demographic (age, gender, BMI) and clinical 
(ASA, comorbidities, number of diseased vessels, 
preoperative wall motion abnormalities, and 
ejection fraction) characteristics were similar in 
both groups (Table 1). 
Figure 1: Intraoperative mean arterial blood pressure 
(MAP) and heart rate (HR) at different time points in 
both study groups. ICCC: intermittent cold crystalloid 
cardioplegia; IWBC: intermittent warm blood 
cardioplegia; CPB: cardiopulmonary bypass 
Procedure data: 
The total volume of cardioplegic solution was 
significantly higher in the warm blood group. Both 
bypass and cross-clamp times were non-
significantly different between both groups. The 
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Table 5: New segmental wall motion abnormality. Categorical variables are presented as number and percent. 
NSWMAs ICCC group (n=17) IWBC group (n=17) p value 
15 minutes after CPB 
    Mild hypokinesia 
    Severe hypokinesia 
    Akinesia 
1 (5.9%) 2 (11.8%) 
0.665 3 (17.6%) 2 (11.8%) 
0 1 (5.9%) 
Sternal closure 
     Mild hypokinesia 
     Severe hypokinesia 
     Akinesia 
1 (5.9%) 2 (11.8%) 
0.685 2 (11.8%) 2 (11.8%) 
0 1 (5.9%) 
NSWMAs: new segmental wall motion abnormalities; ICCC: intermittent cold crystalloid cardioplegia; 
IWBC: intermittent warm blood cardioplegia; CPB: cardiopulmonary bypass.  
significantly longer in the cold crystalloid group 
with a significantly higher incidence of reperfusion 
ventricular arrhythmia (35% versus 6%) 
compared to the warm blood group (Table 2). 
Study outcomes: 
Mean arterial blood pressure and heart rate 
were non-significantly different between both 
groups at all intraoperative time intervals (p= 0.7 
and 0.95, respectively) (Figure 1A and B). 
Both coronary sinus acid production and 
lactate level were significantly higher in the warm 
blood group than in the cold crystalloid group at 1 
minute after removal of the clamp and 15 min 
after reperfusion (Table 3). The intraoperative ECG 
changes were non-significantly different between 
both groups. Moreover, the means of left 
ventricular ejection fraction were non-significantly 
different between both groups 15 minutes after 
bypass and after sternal closure (Table 4). 
The intraoperative occurrence and severity of 
new segmental wall motion abnormalities were 
non-significantly different between both groups 
15 minutes after bypass and after sternal closure 
(Table 5). 
Both creatine kinase-MB (CK-MB) and cardiac 
troponin I (cTnI) levels were non-significantly 
different between both groups at all 
postoperative time points (at 6, 12, and 24 hours) 
(Table 6). 
The postoperative outcomes, including; the 
vasoactive drug use, adverse cardiac events, and 
ICU and hospital stay, were non-significantly 
different between both groups. One patient (6%) 
died because of postoperative MI and low cardiac 
output syndrome in the warm blood group (Table 
7). 
Discussion 
Adequate myocardial protection is the main 
target of the cardioplegic arrest. Despite the 
ongoing research, the optimal cardioplegic 
solution has not been reached yet. 
Table 6: Postoperative biomarkers of myocardial injury. Continuous data are presented as mean± SD. 
Study 
Group 
CK-MB (U/l) p 
value 
Troponin I (ng/ml) p 
























0.438 ± 0.25 





Table 7: Postoperative hospital outcomes in both study groups. Continuous data are presented as mean± SD and 
categorical variables as number and percent. 
ICCC group (n=17) IWBC group (n=17) P-value 
Hemodynamic support 
     Inotropes 
     Vasopressors 
11 (64.7%) 6 (35.3%) 0.086 
5 (29.4%) 4 (23.5%) 0.697 
Adverse cardiac events 
     Death  0 1 (5.9%) 0.310 
     Postoperative MI/CHF 0 1 (5.9%) 0.310 
     AF 0 1 (5.9%) 0.310 
    Need for IABP 0 1 (5.9%) 0.310 
Postoperative stay 
     Stay in ICU (days) 
     Stay in hospital (days) 
2.29 ± 0.77 2.41 ± 0.87 0.678 
9.28 ± 0.76 9.42 ± 0.88 0.623 
AF: atrial fibrillation; ICCC: intermittent cold crystalloid cardioplegia; IWBC: intermittent warm blood cardioplegia; CHF: 
congestive heart failure; IABP: intra-aortic balloon pump; ICU: intensive care unit; MI: myocardial infarction.  
We performed a clinical trial on patients 
undergoing elective primary on-pump isolated 
CABG, comparing intermittent cold crystalloid 
cardioplegia (ICCC) or intermittent warm blood 
cardioplegia (IWBC). The primary objective of this 
study was to assess the impact of administration 
of each cardioplegia solution on myocardium 
metabolism assessed by lactate level measured in 
coronary sinus blood. 
In our study, both groups were matched 
regarding age, gender, BMI, ASA class, 
comorbidities, number of diseased vessels, 
segmental wall motion abnormality, and left 
ventricular ejection fraction. Coronary sinus 
lactate level and acid production were significantly 
greater in the warm blood group than in the cold 
crystalloid group at 1 minute after removal of the 
aortic cross-clamp and at 15 min after reperfusion. 
Several studies showed that warm cardioplegia 
was associated with greater lactate production 
than cold cardioplegia [10, 11]. Borowski and 
coworkers reported a lower lactate release and 
higher pH with cold cardioplegia [12]. 
A meta-analysis reported no statistically 
significant difference between blood cardioplegia 
and crystalloid cardioplegia concerning lactate 
levels at any measured time point [13]. The 
results of the meta-analysis can be explained by 
the fact that the analysis included studies on 
pediatric patients; however, all studies compared 
cold crystalloid to cold blood cardioplegia. 
In the current study, we found that the total 
volume of cardioplegic solution was significantly 
higher in the warm blood group. However, both 
bypass and cross-clamp durations were non-
significantly different between both groups. On 
the other hand, the time taken to regain normal 
sinus rhythm was significantly longer in the cold 
crystalloid group with a substantially higher 
incidence of reperfusion ventricular arrhythmia 
compared to the warm blood group. Nardi and 
associates found that the mean doses of 
cardioplegia were higher in the warm blood group, 
while cardiopulmonary and aortic cross-clamp 
times were similar in both groups [14]. 
In our study, we reported that both heart rate 
and arterial blood pressure were comparable 
between both groups. Additionally, we found that 
the intraoperative ECG ischemic changes and the 
left ventricular ejection fraction after bypass and 
after sternal closure were non-significantly 
different between both groups. Moreover, we 
demonstrated that the intraoperative incidence 
and severity of new segmental wall motion 
abnormalities were comparable between both 
groups.  
Several studies reported no change in EF with 
different types of cardioplegic solutions [14, 15]. 
Poncelet et al. performed a randomized study to 






cardioplegia. They reported no difference in 
EF between the two groups [16].  
Nardi and colleagues reported that 
postoperative EF was better in the cold 
cardioplegia group [17]. This difference in their 
findings compared to our study could be explained 
by the fact that their study included primarily 
patients undergoing aortic valve replacement. In 
the CABG Patch Trial, patients with an EF of <36% 
were assigned to blood or crystalloid cardioplegia 
[18]. They found that ventricular dysfunction was 
less with normothermic blood cardioplegia than 
cold blood cardioplegia. The difference in their 
findings compared to ours could be related to the 
patients' selection; the Patch trial included 
patients with low EF, while we excluded those 
patients.  
In our study, we reported that both creatine 
kinase-MB (CK-MB) and cardiac troponin I (cTnI) 
levels were comparable between both groups. 
Moreover, we found that all postoperative 
outcomes, including; the vasoactive drug use, 
adverse cardiac events, and ICU and hospital stay, 
were comparable between both groups. A meta-
analysis found no difference in mortality, MI, and 
low cardiac output between the blood and 
crystalloid cardioplegia [19]. 
Similarly, Nardi and coworkers reported 
similar serum levels of myocardial enzymes after 
CABG in patients who had cold and blood 
cardioplegia. Additionally, they reported similar 
clinical outcomes in both groups. However, 
postoperative paroxysmal atrial fibrillation was 
higher in the warm blood group, although this 
difference did not reach a statistically significant 
level [17].  
In contrast to the current study, Mourad and 
collaborators [15] found a highly significant 
decrease in the release of cardiac enzymes after 
24 hours in patients who received warm blood 
cardioplegia. The reduction of the myocardial 
release of cTnI was highly significant immediately 
postoperative, 12, and 24 hours after arrival to 
ICU.  
Similarly, Franke and associates reported 
lower CK-MB and cTnI levels with warm blood 
cardioplegia [20]. However, they had a longer 
bypass time in the cold crystalloid group, which 
could lead to higher enzyme levels. Vermes and 
collaborators reported that cTnI concentration 
was closely correlated to cardiopulmonary bypass 
and aortic cross-clamping times [21]. 
Guru and coworkers reported a significant 
increase in CK-MB release with cold crystalloid 
cardioplegia in a meta-analysis of 34 clinical trials 
[1]. The difference in the results of this review 
compared to ours can be explained by the 
different components of blood and crystalloid 
cardioplegia solutions that were used by different 
investigators.  
On the other hand, De Jonge and coworkers 
found higher CK-MB levels in patients who had 
blood cardioplegia [22]. The type of cardioplegia 
did not influence early mortality, postoperative 
low cardiac output syndrome, or intensive care 
unit stay.  
In summary, our study found that myocardial 
metabolism is reduced with the use of cold 
crystalloid cardioplegia compared to the warm 
blood solution; however, this reduction was not 
translated into a difference in the clinical 
outcomes. 
Limitations 
The major limitation of this study was the 
sample size. We were able to detect a difference 
in cardiac metabolism between both cardioplegic 
solutions; however, the sample size may not be 
enough to detect a difference in the clinical 
outcomes. Another limitation is the short follow-
up period, and a longer and larger study is 
recommended. Additionally, this study represents 
a single-center experience, and generalization of 
the results may not be applicable to all centers. 
The results of the study may be affected by the 
composition of the cardioplegic solutions, and 
different components may yield different results. 
Conclusion 
Intermittent antegrade cold crystalloid 
cardioplegia was associated with attenuated 
myocardial metabolism. However, it was 
associated with a longer time to regain normal 





sinus rhythm and more reperfusion ventricular 
arrhythmias. We did not find differences in the 
clinical and echocardiographic outcomes and 
cardiac enzymes between cold crystalloid and 
warm blood cardioplegia. 
Conflict of interest: Authors declare no conflict of 
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